Stayble Therapeutics AB
STABL | ST
Overview
Corporate Details
- ISIN(s):
- SE0013513652 (+1 more)
- LEI:
- 549300WD23DE1US21868
- Country:
- Sweden
- Address:
- Lennart Torstenssonsgatan 6, 412 56 Göteborg
- Website:
- https://staybletherapeutics.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Stayble Therapeutics AB develops injectable treatments for chronic back pain. Their solutions target the root cause of disc-related pain.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Stayble Therapeutics AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
No filings match the current criteria. |
Automate Your Workflow. Get a real-time feed of all Stayble Therapeutics AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Stayble Therapeutics AB via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
|
Curevac | Germany | CVAC | |
![]() |
Cyclezyme AB | Sweden | CYCLE | |
|
Cyxone AB | Sweden | CYXO | |
![]() |
DBV Technologies | France | DBV | |
![]() |
DEINOVE | France | ALDEI | |
![]() |
Deutsche Biotech Innovativ AG | Germany | DBI | |
![]() |
Devyser Diagnostics | Sweden | DVYSR | |
![]() |
Diamyd Medical AB (publ) | Sweden | DMYD | |
|
Diasorin | Italy | DIA | |
DNA Group (T.R.) Ltd. | Israel | DNA |